Francesca Del Sorbo, MD, PhD, is a neurologist specializing in movement disorders and autonomic dysfunction, with more than twenty years of clinical and research experience. Her academic and scientific activity focuses on Parkinson’s disease, atypical parkinsonian syndromes, and the study of dysautonomia, combining clinical biomarkers, neurophysiology, and translational approaches to improve early diagnosis and patient-centered management. She currently serves as Head of the Autonomic Laboratory at the Parkinson Unit of ASST Gaetano Pini-CTO in Milan, Italy.
Her research has contributed to advancing the understanding of disease progression, autonomic impairment, and therapeutic strategies in parkinsonism. She has published extensively on multiple system atrophy, Parkinson’s disease, dystonia, and the development and validation of clinical scales, with more than 40 peer-reviewed publications. Her work also includes studies on peripheral biomarkers such as alpha-synuclein in skin biopsy, the natural history of parkinsonian syndromes, and the biochemical and genetic mechanisms underlying disease heterogeneity.
Dr. Del Sorbo is actively engaged in global health initiatives, particularly through the “Africa Project,” aimed at improving access to diagnosis and treatment of Parkinson’s disease in sub-Saharan Africa, developing low-cost interventions and training local physicians. She also has longstanding experience in teaching, mentoring, and scientific dissemination, contributin
Francesca Del Sorbo, MD, PhD, is a neurologist specializing in movement disorders and autonomic dysfunction, with more than twenty years of clinical and research experience. Her academic and scientific activity focuses on Parkinson’s disease, atypical parkinsonian syndromes, and the study of dysautonomia, combining clinical biomarkers, neurophysiology, and translational approaches to improve early diagnosis and patient-centered management. She currently serves as Head of the Autonomic Laboratory at the Parkinson Unit of ASST Gaetano Pini-CTO in Milan, Italy.
Her research has contributed to advancing the understanding of disease progression, autonomic impairment, and therapeutic strategies in parkinsonism. She has published extensively on multiple system atrophy, Parkinson’s disease, dystonia, and the development and validation of clinical scales, with more than 40 peer-reviewed publications. Her work also includes studies on peripheral biomarkers such as alpha-synuclein in skin biopsy, the natural history of parkinsonian syndromes, and the biochemical and genetic mechanisms underlying disease heterogeneity.
Dr. Del Sorbo is actively engaged in global health initiatives, particularly through the “Africa Project,” aimed at improving access to diagnosis and treatment of Parkinson’s disease in sub-Saharan Africa, developing low-cost interventions and training local physicians. She also has longstanding experience in teaching, mentoring, and scientific dissemination, contributin